Outcomes of Tacrolimus Therapy in Adults With Refractory Membranous Nephrotic Syndrome: A Prospective, Multicenter Clinical Trial-Reference-Cited by-同舟云学术

Outcomes of Tacrolimus Therapy in Adults With Refractory Membranous Nephrotic Syndrome: A Prospective, Multicenter Clinical Trial

Published:2013-02 Issue:2 Volume:345 Page:81-87
ISSN:0002-9629
Container-title:The American Journal of the Medical Sciences
language:en
Short-container-title:The American Journal of the Medical Sciences

Author:

Chen Wei,Liu Qinghua,Ji Yulian,Liu Zhengrong,Yu Xueqing,Liao Yunhua,Yang Zhenhua,Chen Jian,Fu Junzhou,Zhang Jinli,Kong Yaozhong,Fu Ping,Lou Tanqi,Li Zhibin

Publisher

Elsevier BV

Subject

General Medicine

Reference42 articles.

1. Idiopathic membranous glomerulonephritis;Cattran;Kidney Int,2001

2. Idiopathic membranous nephropathy: outline and rationale of a treatment strategy;du Buf-Vereijken;Am J Kidney Dis,2005

3. Prognosis of untreated patients with idiopathic membranous nephropathy;Schieppati;N Engl J Med,1993

4. ; Toronto Glomerulonephritis Registry Group;Troyanov;Idiopathic membranous nephropathy: definition and relevance of a partial remission. Kidney Int,2004

5. A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy;Ponticelli;Kidney Int,1995

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Refractory IgA Nephropathy: A Challenge for Future Nephrologists;Medicina;2024-02-05

2. Tremor Induced by Cyclosporine, Tacrolimus, Sirolimus, or Everolimus: A Review of the Literature;Drugs in R&D;2023-08-22

3. Comparative analysis of the efficacy of different treatments for idiopathic membranous nephropathy: a retrospectively real-world study;Current Medical Research and Opinion;2023-04-03

4. Herbal Medicine “Shulifenxiao” Formula for Nephrotic Syndrome of Refractory Idiopathic Membranous Nephropathy;Frontiers in Pharmacology;2021-05-10

5. A Review of the Current Practice of Diagnosis and Treatment of Idiopathic Membranous Nephropathy in China;Medical Science Monitor;2021-01-27